Ocedurenone

N/A

Report date: 2025/08/05 20:00:05
NME

Base Information

Drug NameOcedurenone
Drug Alias Name阿莫奎尼KBP-5074NN-6023
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMineralocorticoid receptor antagonists
TargetsMineralocorticoid receptor
Therapy Area/IndicationsHypertensionRenal Insufficiency, ChronicRenal Insufficiency +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBosnia and HerzegovinaBulgaria +[22] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesKbp Biosciences
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNovo Nordisk A/SKBP BioSciences Pte Ltd
Inactive CompaniesKbp BiosciencesShandong Hengli Pharmaceutical Technology Co Ltd
Active IndicationsHypertensionNephrosis
Inactive IndicationsRenal Insufficiency, ChronicRenal InsufficiencyKidney Diseases

Other Information

ATC CodeN/A
Related LinksN/A